Leflunomide Tablet, Film Coated
Product Images NDC 59651-348

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Leflunomide (NDC 59651-348). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure1 (Leflunomide Fig1)

Figure1 (Leflunomide Fig1)
FDA Label Image

Figure2 (Leflunomide Fig2)

Figure2 (Leflunomide Fig2)
The text appears to be a graph or chart showing the percentage of responders over time for two treatments, labeled as "pPL-TF-MTX" and "A-LEF". The title suggests that this data is part of a clinical trial labeled as "Trial 1". However, without a visual representation of the graph, it is not possible to provide a more detailed description.*
FDA Label Image

Figure3 (Leflunomide Fig3)

Figure3 (Leflunomide Fig3)
FDA Label Image

Figure4 (Leflunomide Fig4)

Figure4 (Leflunomide Fig4)
FDA Label Image

Package Label-principal Display Panel (10 mg (30 Tablets Bottle Label))

Package Label-principal Display Panel (10 mg (30 Tablets Bottle Label))
Each film-coated tablet contains Leflunomide USP 10 mg. The dosage and administration information can be found in the package insert. It is recommended to keep the tablets out of reach of children and stored at a controlled room temperature between 20-25 degrees Celsius. The tablets should also be protected from moisture. Distributed by Aurobindo Pharma USA, the tablets are manufactured in India. No useful information could be derived from "Over prnting Zone Coding Area".*
FDA Label Image

Package Label-principal Display Panel (20 mg (30 Tablets Bottle Label))

Package Label-principal Display Panel (20 mg (30 Tablets Bottle Label))
FDA Label Image

Structure (Leflunomide Str1)

Structure (Leflunomide Str1)
FDA Label Image

Structure2 (Leflunomide Str2)

Structure2 (Leflunomide Str2)
This is a pharmaceutical drug with the name of teriflunomide, which has a code of F3C and a product code of A77 1726. No further information is available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.